Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Breast Cancer Research and Treatment|December 16, 2019
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant miceDavid R Meier, Megan A Girtman, Kristopher A Lofgren, et al.Archives of Otolaryngology--Head & Neck Surgery|September 1, 1995
Photodynamic therapy for recurrent nasopharyngeal cancerL A Lofgren, S Hallgren, E Nilsson, et al.Plos One|August 19, 2020
Does fungal competitive ability explain host specificity or rarity in ectomycorrhizal symbioses?Peter G Kennedy, Joe Gagne, Eduardo Perez-Pazos, et al.Hormones & Cancer|November 30, 2011
Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progressionAlessia Locatelli, Kristopher A Lofgren, Andrea R Daniel, et al.Antibody Therapeutics|December 8, 2021
Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancerKristopher A Lofgren, Sreeja Sreekumar, E Charles Jenkins, et al.Mbio|September 1, 2021
Aspergillus fumigatus In-Host HOG Pathway Mutation for Cystic Fibrosis Lung Microenvironment PersistenceBrandon S Ross, Lotus A Lofgren, Alix Ashare, et al.Endocrinology|December 1, 1991
In vivo regulation of FSH synthesis by inhibin and activinR S Carroll, P M Kowash, J A Lofgren, et al.Journal of Cutaneous Pathology|June 20, 2017
Genomic analysis of melanoma evolution following a 30-year disease-free intervalJerry J Miller, Kristopher A Lofgren, Sarah R Hughes, et al.Journal of Immunological Methods|September 27, 1993
Monoclonal antibody based ELISAs for measurement of activins in biological fluidsW L Wong, S J Garg, T Woodruff, et al.The Journal of Biological Chemistry|June 5, 1990
Preparation of biologically active 32P-labeled human relaxin. Displaceable binding to rat uterus, cervix, and brainP L Osheroff, V T Ling, R L Vandlen, et al.Pageof 7